Quarterly report pursuant to Section 13 or 15(d)

Inventories, net (Tables)

v3.22.2.2
Inventories, net (Tables)
3 Months Ended
Aug. 31, 2022
Inventories, net  
Summary of Inventories, net of reserves

Inventories were as follows (in thousands):

August 31, 2022

May 31, 2022

Raw materials

$

16,264

$

16,264

Work-in-progress

 

1,665

 

1,665

Total inventories, net

$

17,929

$

17,929

Schedule of remaining shelf life of inventory

Raw Materials

Work-in-progress

(in thousands, Expiration period ending August 31,)

    

Remaining shelf-life (mos)

    

Specialized

Resins

Other

Total Raw Materials

Bulk drug product

Finished drug product

Total inventories

2023

0 to 12

$

3,658

$

-

$

1,421

$

5,079

$

1,824

$

-

$

6,903

2024

13 to 24

682

16,264

1,590

18,536

1,665

-

20,201

2025

25 to 36

2,099

-

-

2,099

-

29,142

31,241

2026

37 to 48

3,435

-

-

3,435

-

32,344

35,779

Thereafter

49 or more

-

-

-

-

-

-

-

Inventories, gross

9,874

16,264

3,011

29,149

3,489

61,486

94,124

Inventory charge

(9,874)

-

(3,011)

(12,885)

(1,824)

(61,486)

(76,195)

Inventories, net

$

-

$

16,264

$

-

$

16,264

$

1,665

$

-

$

17,929